TeleTrader 11/23/2020 Merck to buy COVID therapy candidate maker OncoImmune
GlobeNewswire 11/10/2020 An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
TeleTrader 10/27/2020 Merck revenue rises 1% YoY to $12.6B in Q3
GlobeNewswire 9/17/2020 Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTR...
GlobeNewswire 8/6/2020 Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Pro...
TeleTrader 7/31/2020 Merck EPS rise by 15% to $1.18 in Q2
TeleTrader 7/24/2020 Trump: Big pharma coming to WH to talk prices
GlobeNewswire 7/6/2020 Amid Global Pandemic, Launch of Smart Safety Syringe to Maximize Availability of Life-Saving Medici...
GlobeNewswire 6/24/2020 Yumanity Therapeutics Announces Strategic Research Collaboration and License Agreement with Merck Fo...
TeleTrader 5/26/2020 COVID-19 vaccine time target 'very aggressive' - Merck CEO
TeleTrader 5/26/2020 Merck to work with IAVI on coronavirus vaccine
GlobeNewswire 5/20/2020 Surface Oncology and Merck to Collaborate on Immuno-Oncology Study Evaluating SRF617, Targeting CD39...
TeleTrader 4/28/2020 Merck & Co's EPS climbs 13% to $1.26 in Q1
GlobeNewswire 2/10/2020 ISG Future Workplace Summit to Examine All Aspects of Work in Digital Age
GlobeNewswire 2/6/2020 Vaccinex Announces Three Oral Presentations Highlighting Semaphorin 4D (SEMA4D) at the ASCO-SITC Cli...
TeleTrader 2/5/2020 Merck boosts EPS by 33% in Q4
TeleTrader 12/30/2019 FDA approves Astra Zeneca, Merck & Co. drug
TeleTrader 12/9/2019 Merck to acquire ArQule for $2.7B
TeleTrader 10/29/2019 Merck says Q3 sales jump 12% YoY to $12.4B
TeleTrader 10/22/2019 Dow turns negative
GlobeNewswire 9/3/2019 Merck Grant to Support Smithsonian Future Exhibition on History of American Medicine
TeleTrader 7/30/2019 Merck&Co reports EPS of $1.03 in Q2, up 63% YoY
TeleTrader 6/19/2019 Merck mulling more M&A - reports
TeleTrader 6/18/2019 Merck's lung cancer treatment receives FDA approval
TeleTrader 6/13/2019 IBM, KPMG, Merck, and Walmart work on drug blockchain